Mirae Asset Global ETFs Holdings
INDV icon

Mirae Asset Global ETFs Holdings’s Indivior Pharmaceuticals INDV Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.73M Buy
56,831
+465
+0.8% +$15.4K ﹤0.01% 1245
2025
Q4 		$2.02M Buy
56,366
+5
+0% +$153 ﹤0.01% 1140
2025
Q3 		$1.36M Sell
56,361
-10,125
-15% -$212K ﹤0.01% 1317
2025
Q2 		$980K Buy
+66,486
New +$774K ﹤0.01% 1450

Other funds holding INDV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's INDV Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings increased its Indivior Pharmaceuticals (INDV) stake by 0.82% in Q1 2026, buying an estimated $15.4K and bringing the position to 56,831 shares worth $1.73M. The position accounts for ﹤0.01% of the portfolio, ranked #1245.

Mirae Asset Global ETFs Holdings first reported a position in INDV in Q2 2025 and has held it in 4 quarters since. The position peaked at $2.02M in Q4 2025. 289 funds tracked by Wall St. Rank hold INDV as of Q1 2026.

  • Mirae Asset Global ETFs Holdings held 56,831 shares of Indivior Pharmaceuticals worth $1.73M as of Q1 2026.
  • Mirae Asset Global ETFs Holdings bought 465 Indivior Pharmaceuticals shares in Q1 2026, an estimated $15.4K.
  • Indivior Pharmaceuticals made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #1245 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Indivior Pharmaceuticals in Q2 2025 and has held it in 4 quarters since.
  • Mirae Asset Global ETFs Holdings's Indivior Pharmaceuticals position peaked at $2.02M in Q4 2025.
  • 289 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.